Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 4/2018

01-08-2018 | Editorial

Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation

Authors: Efstathia Andrikopoulou, MD, Pradeep Bhambhvani, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2018

Login to get access

Excerpt

Inflammation-related hot spot imaging along with suppression of physiologic myocardial glucose metabolism forms the basis of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging of inflammatory cardiomyopathies, infections of intracardiac devices, and prosthetic valves and vulnerable coronary plaques. Adequate attenuation of physiologic myocardial glucose uptake that ensures high-quality FDG-PET images, however, can be challenging, especially since glucose can be physiologically taken up by the cardiomyocytes under certain conditions. In order to maximize suppression of normal glucose uptake, a number of different interventions have been proposed and are utilized by PET laboratories, without there being a consensus on the most effective one. …
Literature
1.
2.
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-89.CrossRefPubMed
3.
Asmal AC, Leary WP, Thandroyen F, Botha J, Wattrus S. A dose response study of the anticoagulant and lipolytic activities of heparin in normal subjects. Br J Clin Pharmacol 1979;7:531-33.CrossRefPubMedPubMedCentral
4.
Gaeta C, Fernandez Y, Pavia J, Flotats A, Artigas C, Deportos J, et al. Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection. Eur J Nucl Med Mol Imaging 2011;38:2018-24.CrossRefPubMed
5.
Demeure F, Hanin FX, Bol A, Vincent MF, Pouleur AC, Gerber B, et al. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: Implications for vulnerable coronary plaque imaging. J Nucl Med 2014;55:1629-35.CrossRefPubMed
6.
7.
Giorgetti A, Marras G, Genovesi D, Filidei E, Bottoni A, Mangione M, et al. Effect of prolonged fasting and lower molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac imaging. J Nuc Cardiol 2017.
8.
Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226.CrossRefPubMed
9.
Lum DP, Wandell S, Ko J, Koel MN. Reduction of myocardial 2-deoxy-2[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. Mol Imaging Biol 2002;4:232-37.CrossRefPubMed
10.
Cheng VY, Slomka PJ, Ahlen M, Thomson LE, Waxman AD, Berman DS. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial. J Nucl Cardiol 2010;17:286-91.CrossRefPubMed
11.
Balink H, Hut E, Pol T, Flokstra FJ, Roef M. Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet. J Nucl Med Technol 2011;39:185-89.CrossRefPubMed
12.
Harisankar CN, Mittal BR, Agarwal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG Uptake. J Nucl Cardiol 2011;18:926-36.CrossRefPubMed
13.
Coulden R, Chung P, Sonnex E, Ibrahim Q, Maguire C, Abele J. Suppression of myocardial 18F-FDG uptake with a preparatory ‘‘Atkins-style’’ low-carbohydrate diet. Eur Radiol 2012;22:2221-28.CrossRefPubMed
14.
Kobayashi Y, Kumita S, Fukushima Y, Ishihara K, Suda M, Sakurai M. Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet. J Cardiol 2013;62:314-19.CrossRefPubMed
15.
Kumar P, Patel CD, Singla S, Malhotra A. Effect of duration of fasting and diet on the myocardial uptake of fluoro-2-deoxyglucose (F-18 FDG) at rest. Indian J Nucl Med 2014;29:140-45.CrossRefPubMedPubMedCentral
16.
Morooka M, Moroi M, Ito K, Wu J, Nakagawa T, Kubota K, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesion of cardiac sarcoidosis. EJNMMI Res 2014;4:1.CrossRefPubMedPubMedCentral
17.
Lee HY, Nam HY, Shin SK. Comparison of myocardial F-18 uptake between overnight and non-overnight fasting in non-diabetic healthy subjects. Jpn J Radiol 2015;33:385-91.CrossRefPubMed
18.
Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244-52.CrossRefPubMed
19.
Scholtens AM, Verberne HJ, Budde RP, Lam MG. Additional heparin pre-administration improves cardiac glucose metabolism over low carbohydrate diet alone in 18F-FDG-PET imaging. J Nucl Med 2016;57:568-73.CrossRefPubMed
20.
Lu Y, Grant C, Xie K, Sweiss NJ. Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. Clin Nucl Med 2017;42:88-94.CrossRefPubMed
21.
Soussan M, Brilley PY, Nunes H, Pop G, Ouvrier MJ, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol 2013;20:120-27.CrossRefPubMed
22.
Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;21:166-74.
23.
Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high fat preparation. J Nucl Med 2009;50:563-68.CrossRefPubMed
24.
Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography of inflammation. J Nucl Cardiol 2017;24:86-99.CrossRefPubMed
25.
Tang R, Wang JT, Wang L, Le K, Huang Y, Hickey AJ, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis. Clin Nucl Med 2015.
26.
Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 2005;106:2710-15.CrossRefPubMed
Metadata
Title
Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation
Authors
Efstathia Andrikopoulou, MD
Pradeep Bhambhvani, MD
Publication date
01-08-2018
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 4/2018
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-017-0872-5

Other articles of this Issue 4/2018

Journal of Nuclear Cardiology 4/2018 Go to the issue

Editorial

A further step towards getting cardiac respiratory motion under control

Editor's Page

Raising awareness: A year for multi-modality cardiac imaging

Original Article

Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results

Original Article

Creation and characterization of normal myocardial perfusion imaging databases using the IQ·SPECT system

Images that Teach

The complementary nature of tissue Doppler to 99mTc-PYP imaging in diagnosis of right ventricular cardiac amyloidosis

Original Article

The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits